Epizyme Inc. Stock
Epizyme Inc. Stock
Epizyme Inc. gained 2.160% today.
Based on 3 Buy predictions and 2 Sell predictions the sentiment towards Epizyme Inc. is rather balanced.
Based on the current price of €6.86 the target price of €16.00 shows a potential of 133.168% for Epizyme Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Epizyme Inc. stock. Criterium "EBIT Margin" gathered the most positive votes but regarding "EBIT Margin" there were negative voices in the community.
Pros and Cons of Epizyme Inc. in the next few years
Pros
0
-
Cons
1
Lower EBIT Margin than peer group
1
Bad rating
1
ROE lower than 10% per year
Performance of Epizyme Inc. vs. its peers
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Epizyme Inc. | 2.160% | -2.860% | -10.301% | -50.275% | -28.891% | - | - |
| Aravive, Inc. | 0.440% | -1.304% | -29.612% | -52.708% | -15.140% | - | - |
| Corvus Pharmaceuticals Inc | -2.560% | -5.785% | -19.718% | 7.547% | -24.503% | -74.382% | -83.371% |
| Glycomimetics Inc. | -1.820% | -11.570% | -25.175% | -7.759% | -32.278% | - | - |
Comments
Other discussions about Epizyme Inc. Stock
Trading Epizyme Inc.
Trading Epizyme Inc.
